Abstract:Insufficient supply of organ for allotransplantation made the study on finding new organ resources from animal progress. Pig is regarded as one of the optimal donor animals for human. The major obstacle in this field is hyperacute reaction (HAR), which is triggered after the xenogenic natural antibodies preexisting in recipient blood combine to the antigens on the surface of the endothelium and activate the complement system. alpha-Galactose residues (alpha-Gal) on the endothelial cell have been identified as the major xenoantigens. NJZ Pig has been closely breed since 1938, whose family history is clear. Tissue samples from heart, liver, kidney, pancreas, lung, small intestine, skin, spleen, thymus and lymph node were obtained and embedded in paraffin. The sections were performed the immunohistochemical staining with the sera from health volunteers (including all the blood types) as the primary antibodies as well as the biotin labeled bandeirae simplicifolia I isolectin B4 (BS I-B4), which has specific affinity to alpha-galactose. All the staining sections were compared with the tissues digested with alpha-galactosidase. There was no difference between the antigens recognized by sera of different blood types. alpha-Gal was still the major xenoantigen on the endothelial cells. There might exist non-alpha-Gal antigens on the distal convoluted tubules and collecting tubules of the kidney. There was no alpha-Gal distributing on the secreting part of pancreas, either the islet cells or the matrix cells, but surely on pancreatic duct and vessels. All the antigenity was destroyed after the enzyme digestion except that the small intestine gland still positive with the BS I-B4. alpha-Gal is the major xenogenic antigen in NJZ Pigs. There exist some unknown antigens on the distal convoluted tubules and collecting ducts of the kidney. The blood type of recipient is not the first affair to be considered in pig-to-human xenotransplantation. The specificity of BS I-B4 for the alpha-galactose needs more detail research.

Production of Human Blood Group B Antigen Epitope Conjugated Protein in Escherichia Coli and Utilization of the Adsorption Blood Group B Antibody

Escherichia Coli O86 O-Antigen Biosynthetic Gene Cluster and Stepwise Enzymatic Synthesis of Human Blood Group B Antigen Tetrasaccharide

Bacterial homologue of human blood group A transferase.

Diversity-Oriented Enzymatic Modular Assembly of ABO Histo-blood Group Antigens

Identification of a new α1,2-fucosyltransferase involved in O-antigen biosynthesis of Escherichia coli O86:B7 and formation of H-type 3 blood group antigen

The preparation, characterization, and application of environment-friendly monoclonal antibodies for human blood cell

Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood

ABO Blood System: Biosynthesis of Agglutinogenic Alkaline and Non-Agglutinogenic Acid Glycotopes of A and B Antigens at Different pHs of the Culture Medium

Enzymatic conversion of human blood group A kidneys to universal blood group O

Chemical Resolution of an Epitope Recognized by Blood Group Antibodies Capable of Binding Both A and B Red Blood Cells

Development of Two Potential Diagnostic Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein B

[Reactivity of Tissues of Chinese NJZ Pig to Human Serum].

ABO‐incompatible Living Kidney Transplantation

Binding of human natural antibodies to nonalphaGal xenoantigens on porcine erythrocytes

Antigenically shielded universal red blood cells by polydopamine-based cell surface engineering

Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alpha1,3Gal epitope

Abo-Incompatible Living Kidney Transplantation

Red Blood Cell Membrane‐Coated Nanoparticles Enable Incompatible Blood Transfusions

The Influence of HK2 Blood Group Antigen on Human B Cell Activation for ABOi-KT Conditions.

Production of antibodies and antibody fragments containing non-natural amino acids in Escherichia coli

Eliminating Xenoantigen Expression on Swine RBC